LVIS Junior 172516-LVISJRecalls & reported problems
Microvention, Inc. · Low-Profile Visualized Intraluminal Support · Class f · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00811425029893), received between Jul 28, 2017 and May 26, 2018 — classified as 1 death, 1 injury.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Insufficient Device Problem Information1
Patient problems
- Thrombus2
- Death1
- Numbness1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryMay 26, 2018Insufficient Device Problem Information; Insufficient Device Problem Information
IT WAS REPORTED THAT THE LVIS JR. WAS IMPLANTED DURING STENT-ASSISTED COILING OF AN ANEURYSM AT THE RIGHT MCA BIFURCATION. THERE WAS NO REPORTED DIFFICULTY DEPLOYING THE STENT AT THE TREATMENT SITE. DURING THE PROCEDURE, AN IN-STENT THROMBUS DEVELOPED AND A BALLOON WAS USED FOR TREATMENT. COILS WERE SUCCESSFULLY PLACED IN THE ANEURYSM AND THE THROMBUS WAS COMPLETELY RESOLVED BY THE END OF THE PROCEDURE. THE PATIENT WAS PLACED ON (B)(6) AS DUAL ANTIPLATELET THERAPY (DAPT), POST-PROCEDURE. ON (B)(6) 2018, APPROXIMATELY ONE MONTH AFTER THE PROCEDURE, THE PATIENT HAD A 20-MINUTE EPISODE OF LEFT ARM NUMBNESS AND DID NOT HAVE THE ABILITY TO USE HER ARM DURING THAT TIME. FIVE DAYS LATER ON (B)(6) 2018, THE PATIENT HAD A SECOND EPISODE WITH THE SAME SYMPTOMS. THE PATIENT WAS ADMITTED TO THE HOSPITAL AND DETAILED IMAGING STUDIES WERE PERFORMED. IT WAS REPORTED THAT THERE WAS NO EVIDENCE BY IMAGING OF EMBOLI OR RESTRICTED BLOOD FLOW. THE PATIENT'S (B)(6) DOSAGE WAS INCREASED. A REVIEW OF IMAGES PROVIDED BY THE CUSTOMER INDICATED THE STENT DID NOT APPEAR TO BE FULLY APPOSED TO THE VESSEL WALL. THE PATIENT IS REPORTED TO BE STABLE AND HAS NOT HAD ANY RECURRENCE OF SYMPTOMS SINCE HER LAST EPISO
Patient problems: Numbness; Thrombus
MAUDE report 7547162 ↗DeathJul 28, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT TREATMENT WAS PERFORMED ON A WIDE-NECK BASILAR ARTERY ANEURYSM OM (B)(6) 2017. FIVE COILS WERE PLACED IN THE ANEURYSM, ASSISTED BY A BALLOON. ALL COILS WERE IMPLANTED IN THE INTENDED LOCATION. AFTER PLACEMENT OF THE COILS, THE LVIS JR. STENT WAS SUCCESSFULLY DEPLOYED AND THE PROCEDURE WAS COMPLETED. THERE WAS NO REPORTED DIFFICULTY DEPLOYING THE STENT. SOMETIME AFTER THE PROCEDURE, THE PATIENT WAS ADMITTED TO THE HOSPITAL (ADMISSION DATE NOT PROVIDED) AND IMAGING DEMONSTRATED IN-STENT THROMBUS. ONE WEEK PRIOR TO THE PROCEDURE, THE PATIENT'S PRU WAS 190. AT THAT TIME, THE PATIENT WAS PLACED ON A DOUBLE DOSE OF PLAVIX. THE PRU ON THE DAY OF THE PROCEDURE WAS 191. THE PATIENT DIED ON (B)(6) 2017. THE PRU WAS NOT CHECKED ON THE DATE OF THE PATIENT'S DEATH. THE CAUSE OF THE DEATH IS UNKNOWN.
Patient problems: Death; Thrombus
MAUDE report 6752843 ↗
Other Intracranial Neurovascular Stent devices
- CERENOVUS ENTERPRISE ENF402312Medos International Sàrl · intracranial neurovascular stent1 death90 reports
- PulseRider Aneurysm Neck Reconstruction Device 201-DMedos International Sàrl · Intracranial Neurovascular Stent2 deaths74 reports
- CERENOVUS ENTERPRISE ENF402300Medos International Sàrl · intracranial neurovascular stent2 deaths66 reports
- CERENOVUS ENTERPRISE ENF403012Medos International Sàrl · intracranial neurovascular stent1 death42 reports
- CERENOVUS ENTERPRISE ENF452212Medos International Sàrl · intracranial neurovascular stent41 reports
- CERENOVUS ENTERPRISE ENF401612Medos International Sàrl · intracranial neurovascular stent36 reports
- CERENOVUS ENTERPRISE ENF401600Medos International Sàrl · intracranial neurovascular stent36 reports
- CERENOVUS ENTERPRISE ENF452812Medos International Sàrl · intracranial neurovascular stent31 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page